{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:40:02Z","timestamp":1718689202615},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.clindermatol.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T04:45:50Z","timestamp":1468125950000},"page":"678-689","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune collagen vascular diseases: Kids are not just little people"],"prefix":"10.1016","volume":"34","author":[{"given":"Sean","family":"Timpane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Brandling-Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arni K.","family":"Kristjansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.07.002_bb0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: Part I. epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: A review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0020","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1085-5629(99)80019-4","article-title":"Morphea and localized scleroderma in children","volume":"18","author":"Vierra","year":"1999","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpeds.2006.04.052","article-title":"Congenital localized scleroderma","volume":"149","author":"Zulian","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1525-1470.2006.00182.x","article-title":"Congenital skin lesions presenting as morphea in a 4-year-old","volume":"23","author":"Joshi","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): Review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0050","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphoea disease severity: A retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphoea follows Blaschko's lines","volume":"159","author":"Weibel","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0060","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0065","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: A retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0075","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma: A case report and literature review","volume":"71","author":"Kister","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1440-1754.2012.02435.x","article-title":"Odontostomatologic involvement in juvenile localised scleroderma of the face","volume":"48","author":"Trainito","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0085","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.5037\/jomr.2011.2205","article-title":"Parry-Romberg syndrome: A rare case report","volume":"2","author":"Rangare","year":"2011","journal-title":"J Oral Maxillofac Res"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11926-012-0308-9","article-title":"Recent developments in diagnosis and assessment of morphea","volume":"15","author":"Nouri","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0095","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: A work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: A proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The localized scleroderma cutaneous assessment tool: Responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: Part II. Outcome measures and treatment","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/pde.12001","article-title":"A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings","volume":"29","author":"Chiu","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0120","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma: A multi-centre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000113889","article-title":"Choroidal sclerosis in localized scleroderma (morphea en plaque)","volume":"40","author":"Milenkovic","year":"2008","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0135","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","article-title":"Morphea in adults and children cohort III: Nested case-control study\u2014the clinical significance of autoantibodies in morphea","volume":"149","author":"Dharamsi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0140","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0145","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/jamadermatol.2013.4908","article-title":"Practice gaps: Evaluating the clinical utility of autoantibodies in morphea","volume":"149","author":"Chiu","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0150","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar4378","article-title":"Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma","volume":"15","author":"Magee","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0155","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2012.01.011","article-title":"Morphea in adults and children cohort II: Patients with morphea experience delay in diagnosis and large variation in treatment","volume":"67","author":"Johnson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(97)80221-6","article-title":"Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma","volume":"36","author":"Hunzelmann","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0165","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma","volume":"43","author":"Hulshof","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0175","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A systematic review of morphea treatments and therapeutic algorithm","volume":"65","author":"Zwischenberger","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0.1% in active plaque morphea: Randomized, double-blind, emollient-controlled pilot study","volume":"10","author":"Kroft","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1346-8138.2008.00552.x","article-title":"Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study","volume":"35","author":"Stefanaki","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","article-title":"First case series on the use of calcipotriol-betamethasone dipropionate for morphoea","volume":"157","author":"Dytoc","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0195","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","article-title":"First case series on the use of imiquimod for morphoea","volume":"153","author":"Dytoc","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"39","author":"Cunningham","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0210","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0215","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0220","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.110210","article-title":"Methotrexate and corticosteroids in the treatment of localized scleroderma: A standardized prospective longitudinal single-center study","volume":"39","author":"Torok","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0225","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","volume":"141","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Low-dose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/09546634.2013.806769","article-title":"Linear morphea: A case series with long-term follow-up of young, methotrexate-treated patients","volume":"24","author":"Koch","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0245","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1365-2133.2008.09017.x","article-title":"Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: An inception cohort study","volume":"160","author":"Kroft","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0250","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate","volume":"33","author":"Fitch","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0255","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in paediatric morphoea","volume":"166","author":"Mirsky","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0265","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3899\/jrheum.090708","article-title":"Treatment of pediatric localized scleroderma: Results of a survey of North American pediatric rheumatologists","volume":"37","author":"Li","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0275","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0280","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archdermatol.2008.547","article-title":"Extracorporeal photochemotherapy for generalized deep morphea","volume":"145","author":"Neustadter","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0290","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/j.1525-1470.2012.01882.x","article-title":"Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate","volume":"30","author":"Inamo","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0295","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","article-title":"Misdiagnosis and delay in referral of children with localized scleroderma","volume":"165","author":"Weibel","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0300","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaad.2013.11.037","article-title":"Correlates of self-reported quality of life in adults and children with morphea","volume":"70","author":"Das","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.100447","article-title":"Influence of childhood scleroderma on physical function and quality of life","volume":"38","author":"Baildam","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0310","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/archderm.144.10.1394","article-title":"Physical burden of symptoms in patients with localized scleroderma and eosinophilic fasciitis","volume":"144","author":"Kroft","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0315","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archdermatol.2009.202","article-title":"Psychological distress in patients with morphea and eosinophilic fasciitis","volume":"145","author":"Kroft","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0320","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar4198","article-title":"Adult and juvenile dermatomyositis: Are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?","volume":"15","author":"Tansley","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0325","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0330","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: A nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0335","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","article-title":"Juvenile dermatomyositis as a pareneoplastic phenomenon: An update","volume":"32","author":"Morris","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0340","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0345","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/BOR.0b013e328331927e","article-title":"Juvenile dermatomyositis: Extramuscular manifestations and their management","volume":"21","author":"Lowry","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0350","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0355","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archderm.1994.01690100078013","article-title":"Dermatomyositis with normal muscle enzymes concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound","volume":"130","author":"Stonecipher","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RMR.0b013e31825b2c35","article-title":"Magnetic resonance imaging of inflammatory myopathies","volume":"22","author":"Del Grande","year":"2011","journal-title":"Top Magn Reson Imaging"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0365","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-4632.2011.05449.x","article-title":"A comparative study of clinical characteristics, work up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore","volume":"52","author":"Yosipovitch","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0370","first-page":"729","article-title":"Interstitial lung disease in classic skin-predominant dermatomyositis. A retrospective study with screening recommendations","volume":"146","author":"Morganoroth","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0375","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","article-title":"Morbidity and mortality in adult polymyositis and dermatomyositis","volume":"14","author":"Marie","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0380","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality of polymyositis and dermatomyositis patients","volume":"25","author":"Airio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0385","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr.22142","article-title":"Clinical characteristics of children with juvenile dermatomyositis: The childhood arthritis and rheumatology research alliance registry","volume":"66","author":"Robinson","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0390","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","volume":"15","author":"Gordon","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0395","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: Current trend in pathogenesis, clinical features, and up-to-date treatment recommendations","volume":"88","author":"Ernest","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0400","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis (JDM) across North America: The childhood arthritis and rheumatology research alliance (Carra) JDM treatment survey","volume":"37","author":"Stinger","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0405","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: Diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0410","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005792-197603000-00006","article-title":"Chronic cutaneous lupus erythematosus (DLE)--a clinical and laboratory investigation of 80 patients","volume":"55","author":"Prystowsky","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0415","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096120339200100310","article-title":"The sequelae of chronic cutaneous lupus erythematosus","volume":"1","author":"de Berker","year":"1992","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0420","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0425","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0025-7125(16)30619-8","article-title":"Chronic cutaneous lupus erythematosus","volume":"73","author":"Hymes","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0430","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0025-7125(16)30621-6","article-title":"Cutaneous lesions in systemic lupus erythematosus","volume":"73","author":"Watson","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0435","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1525-1470.2003.20402.x","article-title":"Childhood discoid lupus erythematosus: A Tunisian retrospective study of 16 cases","volume":"20","author":"Cherif","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0440","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archderm.1993.01680260083012","article-title":"Childhood discoid lupus erythematosus","volume":"129","author":"George","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0445","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjd.12383","article-title":"Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre","volume":"169","author":"Dickey","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1468-3083.2002.00385.x","article-title":"Childhood discoid lupus erythematosus: Report of five new cases and review of the literature","volume":"16","author":"Van Gysel","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0455","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1525-1470.2008.00625.x","article-title":"Discoid lupus erythematosus in children\u2014a retrospective study of 34 patients","volume":"25","author":"Sampaio","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0460","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1525-1470.2003.20201.x","article-title":"Discoid lupus erythematosus in children: Clinical, histopathologic, and follow-up features in 27 cases","volume":"20","author":"Moises-Alfaro","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0465","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2133.1998.02373.x","article-title":"Linear cutaneous lupus erythematosus following the lines of Blaschko","volume":"139","author":"Abe","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0470","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1525-1470.1999.00030.x","article-title":"Linear childhood discoid lupus erythematosus following the lines of Blaschko: A case report with review of the linear manifestations of lupus erythematosus","volume":"16","author":"Green","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0475","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1525-1470.2010.01249.x","article-title":"Linear childhood discoid lupus erythematosus following the lines of Blaschko: Successfully treated with topical tacrolimus","volume":"28","author":"Kawachi","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0480","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1470.1996.tb01236.x","article-title":"Histopathology and immunofluorescence of discoid lupus erythematosus in children","volume":"13","author":"George","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0485","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555577305308","article-title":"Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients","volume":"77","author":"Tebbe","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0490","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clindermatol.2003.12.018","article-title":"Clinical course and prognosis of cutaneous lupus erythematosus","volume":"22","author":"Tebbe","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0495","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jaad.2010.02.008","article-title":"Quality of life in cutaneous lupus erythematosus","volume":"64","author":"Klein","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2012.11106.x","article-title":"A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus","volume":"168","author":"Vasquez","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0505","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1525-1470.2009.00916.x","article-title":"Dramatic response of scarring scalp discoid lupus erythematosus (DLE) to intravenous methylprednisolone, oral corticosteroids, and hydroxychloroquine in a 5-year-old child","volume":"26","author":"Miettunen","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0510","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/pde.12248","article-title":"Pediatric cutaneous lupus erythematosus treated with pulsed dye laser","volume":"31","author":"Yelamos","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0515","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaad.2008.11.904","article-title":"Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus","volume":"60","author":"Erceg","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0520","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2133.1992.tb00670.x","article-title":"Scarring alopecia in discoid lupus erythematosus","volume":"126","author":"Wilson","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0525","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/RHU.0b013e3182051928","article-title":"Squamous cell carcinomas arising in discoid lupus erythematosus scars: Unusual occurrence in an African-American and in a sun-protected area","volume":"17","author":"Alsanafi","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0530","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","article-title":"Lupus erythematosus: Systemic and cutaneous manifestations","volume":"24","author":"Rothfield","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0535","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus","volume":"166","author":"Chong","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.07.002_bb0540","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.berh.2013.07.007","article-title":"Paediatric-onset systemic lupus erythematosus","volume":"27","author":"Malattia","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16301791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16301791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:10:14Z","timestamp":1718687414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16301791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0738081X16301791"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.07.002","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune collagen vascular diseases: Kids are not just little people","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}